Trademarkia Logo

Canada

C$
UltraHuman Research
FORMALIZED

on 16 May 2025

Last Applicant/ Owned by

13314201 Canada Inc

8 Francine CourtWoodbridge

ONTARIO

CA

L4L1P4

Serial Number

2399548 filed on 16th May 2025

UltraHuman Research

Trademark usage description

adult vitamins; amino acid dietary supplements; anti-aging vitamin supplements; anti-hangover supplement in liquid form; anti-inflammatory nutritional Read More

Classification Information


Class [005]
Adult vitamins; amino acid dietary supplements; anti-aging vitamin supplements; anti-hangover supplement in liquid form; anti-inflammatory nutritional supplements; anti-oxidants for use as dietary supplements; antioxidant dietary supplements; baby vitamins; beta carotene supplements; blueberry extract dietary supplements; botanical supplements for general health and well-being; branched-chain amino acid (BCAA) dietary supplements; calcium supplements; calcium supplements in chewable solid form; casein dietary supplements; children's vitamins; coenzyme q10 dietary supplements; collagen dietary supplements; creatine powder dietary supplements; dietary and nutritional supplements containing mushroom in powdered form for boosting immunity; dietary and nutritional supplements containing mushroom in powdered form for general health and well-being; dietary and nutritional supplements containing mushroom in powdered form for maintaining a healthy digestive system; dietary and nutritional supplements containing vitamins for hair loss; dietary and nutritional supplements for building body mass; dietary and nutritional supplements for general health and well being; dietary and nutritional supplements for general health and wellbeing; dietary and nutritional supplements for humans containing psilocybin mushroom for recreational purposes; dietary and nutritional supplements for maintaining a healthy digestive system; dietary and nutritional supplements for women's general health and well-being; dietary and nutritional supplements in gel capsule form that contain ganoderma lucidum and vitamins; dietary and nutritional supplements in the form of gummies for general health and well-being; dietary and nutritional supplements to support iron levels and to treat iron-deficiency anemia; dietary and nutritional supplements used for energy stimulation; dietary and nutritional supplements used for thermogenesis; dietary and nutritional supplements used for weight loss; dietary food supplements in the nature of mixed herbal infusions for maintaining normal blood pressure and heart function; dietary food supplements in the nature of mixed herbal infusions for reducing cholesterol; dietary food supplements in the nature of ready-to-eat protein bars; dietary food supplements in the nature of ready-to-eat protein bars for medical purposes; dietary supplement drink mixes for general health and wellbeing; dietary supplement drinks containing ginseng for general health and well-being; dietary supplement drinks for general health and well being; dietary supplement for eliminating toxins from the intestinal tract; dietary supplemental drinks containing adaptogens for general health and well-being; dietary supplements and nutritional supplements for treatment of dry eyes; dietary supplements consisting of amino acids; dietary supplements consisting of minerals; dietary supplements consisting of trace elements; dietary supplements consisting of vitamins; dietary supplements consisting primarily of calcium; dietary supplements consisting primarily of iron; dietary supplements consisting primarily of magnesium; dietary supplements containing adaptogens for general health and well-being; dietary supplements for body weight control; dietary supplements for controlling cholesterol; dietary supplements for enhancing the immune system; dietary supplements for general health and well-being; dietary supplements for humans containing cannabinoids for medicinal purposes; dietary supplements for humans containing cannabis derivatives for medicinal purposes; dietary supplements for humans containing cannabis for medicinal purposes; dietary supplements for humans containing marijuana derivatives for medicinal purposes; dietary supplements for humans containing marijuana for medicinal purposes; dietary supplements for humans for the prevention and treatment of iron deficiency and anaemia in humans; dietary supplements for maintaining normal blood pressure and heart function; dietary supplements for promoting weight loss; dietary supplements for reducing cholesterol; dietary supplements to reduce muscle cramps and nausea; effervescent vitamin tablets; essential fatty acid supplements; ginseng dietary supplements; glucose dietary supplements; gummy vitamins; gummy vitamins containing cannabinoids for recreational purposes; gummy vitamins containing cannabis derivatives for medicinal purposes; hemp-based dietary supplements; hemp-based food supplements; hemp-based nutritional supplements; hemp-based powder dietary supplements; herbal and dietary supplements for enhancing and increasing athletic performance; herbal and dietary supplements for promoting faster muscle recovery after exercise; herbal nutritional supplements in the form of powders for general health and well-being; herbal supplements for boosting the immune system and cognitive capacity; herbal supplements for general health and well-being; herbal supplements for men's mental health; herbal supplements for promoting anti-aging benefits; herbal supplements for sleeping problems; herbal supplements for the promotion of healthy liver function; herbal supplements for the treatment of arthritis; herbal supplements for the treatment of cancer; herbal supplements for the treatment of cardiovascular diseases; herbal supplements for the treatment of dental and oral diseases; herbal supplements for the treatment of headaches; herbal supplements for the treatment of menopause; herbal supplements for the treatment of the respiratory system; herbal supplements for use in oncology; iron supplements; liquid vitamin supplements; magnesium dietary supplements; medicated beverages in the nature of dietary supplements for colon detoxification; medicated beverages in the nature of dietary supplements for liver detoxification; medicated beverages in the nature of psilocybin botanical supplements for the treatment of mental health disorders; medicated food supplements being tablets for maintaining normal blood pressure and heart function; medicated food supplements being tablets for reducing cholesterol; mineral dietary supplements; mineral dietary supplements for humans; mineral nutritional supplements; mineral supplements; minerals; mushroom and herbal supplements for general health and well-being; natural dietary supplements for treating claustrophobia; natural supplements for endometriosis symptom relief; natural supplements for polycystic ovary syndrome symptom relief; natural supplements for treating candida; natural supplements for treating depression and anxiety; natural supplements for treating erectile dysfunction; natural supplements to maintain sexual health; nutraceutical dietary supplement for maintaining general health and wellbeing; nutraceuticals as a sleep aid; nutraceuticals containing cannabis as a sleep aid; nutraceuticals containing cannabis for maintaining general health and well being; nutraceuticals containing cannabis for management of opioid addiction; nutraceuticals containing cannabis for reducing stress and fatigue; nutraceuticals containing cannabis for relieving depression; nutraceuticals containing cannabis for the relief of epilepsy; nutraceuticals containing cannabis for the relief of pain; nutraceuticals for reducing stress and fatigue; nutraceuticals for relieving anxiety; nutraceuticals for the management of opioid addiction; nutraceuticals for the relief of epilepsy; nutraceuticals for the relief of pain; nutraceuticals for use as a dietary supplement for general health and well-being; nutritional dietary supplements for boosting immunity; nutritional food supplements in the form of mushroom powders for general health and well-being; nutritional supplement containing vitamins and amino acids to support hangover recovery; nutritional supplement drink mixes and powders for general health and well-being; nutritional supplement for eliminating toxins from the intestinal tract; nutritional supplement for eliminating toxins from the liver; nutritional supplement meal replacement bars containing vitamins and minerals; nutritional supplement meal replacement bars for boosting energy; nutritional supplement meal replacement beverages containing vitamins and minerals; nutritional supplement meal replacement powders containing vitamins and minerals; nutritional supplements as a sleep aid; nutritional supplements consisting of vitamins and minerals; nutritional supplements consisting primarily of calcium; nutritional supplements consisting primarily of iron; nutritional supplements consisting primarily of magnesium; nutritional supplements consisting primarily of zinc; nutritional supplements containing adaptogens for general health and well-being; nutritional supplements containing cannabinoids for medicinal purposes; nutritional supplements containing cannabis for medicinal purposes; nutritional supplements containing marijuana for medicinal purposes; nutritional supplements designed to alleviate the symptoms of amino acid metabolic disorders; nutritional supplements designed to alleviate the symptoms of hangover; nutritional supplements for boosting energy; nutritional supplements for brain development; nutritional supplements for building body mass; nutritional supplements for general health and well being; nutritional supplements for general health and well-being; nutritional supplements for infant and child health and well-being; nutritional supplements for maintaining a healthy digestive system; nutritional supplements for prenatal and postnatal health and well-being; nutritional supplements for prenatal and postnatal health and wellbeing; nutritional supplements for promoting hair growth; nutritional supplements for reducing stress; nutritional supplements for relief of pain; nutritional supplements for the prevention and treatment of histamine intolerance; nutritional supplements for the prevention and treatment of varicose veins and other vein disorders; nutritional supplements for the promotion of efficient metabolism of alcohol; nutritional supplements in the form of gummies for general health and well-being; nutritional supplements to boost energy and improve focus; nutritional supplements to boost the immune system; omega-3 fatty acid supplements; omega-3 fatty acid supplements for pets; omega-3 monoglycerides supplements; oral nutritional supplements containing herbal extracts for general health and well-being; oral nutritional supplements containing herbal extracts to improve physical conditioning; oral nutritional supplements containing herbs for general health and well-being; oral nutritional supplements containing herbs to improve physical conditioning; pectin for pharmaceutical purposes; pepsins for pharmaceutical purposes; pharmaceutical agents for treating physically caused lesions; pharmaceutical anti-allergic medications; pharmaceutical anti-allergic preparations and substances; pharmaceutical anti-inflammatories; pharmaceutical anti-viral agents; pharmaceutical antiallergic preparations and substances; pharmaceutical antibodies for the treatment of hereditary angioedema (HAE); pharmaceutical antibodies for the treatment of respiratory diseases and respiratory syndromes; pharmaceutical antibody preparations for auto-immune diseases; pharmaceutical antibody preparations for respiratory disease; pharmaceutical antibody preparations for the prevention and treatment of auto-immune diseases; pharmaceutical antibody preparations for the treatment of cancer; pharmaceutical antitussive-cold preparations; pharmaceutical anxiolytic medications; pharmaceutical astringents; pharmaceutical cold preparations; pharmaceutical cough preparations; pharmaceutical creams that facilitate the topical administration of pharmaceuticals for the treatment of dermatological conditions being dermatitis, eczema and psoriasis; pharmaceutical enzymes for use as gene editor for the treatment of genetic diseases and disorders; pharmaceutical for the treatment of erectile dysfunction; pharmaceutical grade lactose; pharmaceutical hormonal preparations, namely, corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; pharmaceutical preparation for the treatment of cold agglutinin disease; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and compositions for the treatment and prevention of cancer in animals; pharmaceutical preparations and substances for the prevention and treatment of Respiratory Syncytial Virus (RSV); pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances for the prevention of diabetes; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the treatment of diabetes; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations and substances for the treatment of gastrointestinal diseases; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for use in urology; pharmaceutical preparations for controlling cholesterol; pharmaceutical preparations for diagnosing and treating neurodegenerative diseases; pharmaceutical preparations for human use in the field of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for human use that modulate the immune system; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of cancer; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; pharmaceutical preparations for hydrating the skin during pregnancy; pharmaceutical preparations for inducing erections; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations for maintaining normal blood pressure and heart function; pharmaceutical preparations for ocular or intraocular surgery; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for preventing skin blemishes during pregnancy; pharmaceutical preparations for prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for reducing cholesterol; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for stimulating human fertility; pharmaceutical preparations for suppressing tumours; pharmaceutical preparations for the diagnosis and treatment of oncological diseases and disorders; pharmaceutical preparations for the diagnosis of oncological diseases and disorders; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of cerebrovascular diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and treatment of iron deficiency and anaemia in humans; pharmaceutical preparations for the prevention and treatment of iron deficiency and anemia in humans; pharmaceutical preparations for the prevention and treatment of lysosomal storage diseases; pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders, namely diabetes, gout, arthritis and anemia; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for the prevention and treatment of muscular atrophy; pharmaceutical preparations for the prevention and treatment of oncological diseases; pharmaceutical preparations for the prevention and treatment of ophthalmic diseases; pharmaceutical preparations for the prevention and treatment of pulmonary hypertension and pulmonary arterial hypertension; pharmaceutical preparations for the prevention and treatment of renal disease and disorders; pharmaceutical preparations for the prevention and treatment of respiratory diseases; pharmaceutical preparations for the prevention and treatment of scleroderma digital ulcers; pharmaceutical preparations for the prevention and treatment of sequelae of oncologic diseases and their treatment namely nausea and vomiting, hematologic depression, mucositis, cachexia, pain and bone pain, fatigue; pharmaceutical preparations for the prevention and treatment of smoking habits and addictions; pharmaceutical preparations for the prevention and treatment of thrombosis; pharmaceutical preparations for the prevention of osteoporosis; pharmaceutical preparations for the prevention of stretch marks; pharmaceutical preparations for the prevention, diagnosis, and treatment of cancer; pharmaceutical preparations for the prevention, diagnosis, and treatment of HIV; pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products in the treatment of oncological diseases; pharmaceutical preparations for the relief of insect bites; pharmaceutical preparations for the relief of pain; pharmaceutical preparations for the treatment and management of vasomotor symptoms and symptoms associated with menopause; pharmaceutical preparations for the treatment and prevention of hiv infection; pharmaceutical preparations for the treatment and prevention of migraines, headaches and pain; pharmaceutical preparations for the treatment and the prevention of dementia; pharmaceutical preparations for the treatment of acne; pharmaceutical preparations for the treatment of acute respiratory distress syndrome (ARDS); pharmaceutical preparations for the treatment of allergic rhinitis; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for the treatment of alopecia and androgenic alopecia; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of asthma; pharmaceutical preparations for the treatment of atherosclerosis; pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of autonomic nerve disorders; pharmaceutical preparations for the treatment of autosomal dominant polycystic kidney disease; pharmaceutical preparations for the treatment of bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections; pharmaceutical preparations for the treatment of blackheads; pharmaceutical preparations for the treatment of blood disorders; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for the treatment of bone fractures; pharmaceutical preparations for the treatment of brain diseases and disorders, namely, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, multiple sclerosis; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of cardiovascular disorders; pharmaceutical preparations for the treatment of carpal tunnel syndrome; pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations for the treatment of cerebral palsy; pharmaceutical preparations for the treatment of chronic liver diseases; pharmaceutical preparations for the treatment of chronic pain; pharmaceutical preparations for the treatment of chronic rhino sinusitis with nasal polyps; pharmaceutical preparations for the treatment of cranial or facial nerve disorders; pharmaceutical preparations for the treatment of cystic fibrosis; pharmaceutical preparations for the treatment of cystinosis of the eye; pharmaceutical preparations for the treatment of damaged skin and tissue namely bee stings, sunburn, rashes, sores, corns, calluses and acne; pharmaceutical preparations for the treatment of dandruff; pharmaceutical preparations for the treatment of degenerative nerve diseases and disorders, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease and multiple sclerosis; pharmaceutical preparations for the treatment of dental and oral diseases; pharmaceutical preparations for the treatment of dermatitis, eczema and psoriasis; pharmaceutical preparations for the treatment of dermatitis, skin pigmentation diseases and psoriasis; pharmaceutical preparations for the treatment of dermatological conditions being acne, rosacea, ichthyosis, vitiligo, urticaria and alopecia areata; pharmaceutical preparations for the treatment of dermatological diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin and bacterial skin infections and fungal skin infections.; pharmaceutical preparations for the treatment of dermatological diseases and disorders namely fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema, and sexually transmitted diseases; pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for the treatment of diabetes in animals; pharmaceutical preparations for the treatment of digestive diseases; pharmaceutical preparations for the treatment of digestive diseases and disorders, namely, crohn's disease, irritable bowel syndrome; pharmaceutical preparations for the treatment of digestive diseases and disorders, namely, ulcerative colitis; pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders; pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders, and neuromuscular diseases, namely primary periodic paralysis; pharmaceutical preparations for the treatment of diseases, disorders and infections of the spinal cord systems and related cartilage and tissue; pharmaceutical preparations for the treatment of drug and alcohol abuse; pharmaceutical preparations for the treatment of duchenne muscular dystrophy; pharmaceutical preparations for the treatment of endocrine diseases, namely, glucagonoma; pharmaceutical preparations for the treatment of epilepsy; pharmaceutical preparations for the treatment of erectile dysfunction; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the treatment of eye infections; pharmaceutical preparations for the treatment of gastro-intestinal diseases; pharmaceutical preparations for the treatment of gastroenterological, intestine, bowel, stomach and digestive disorders; pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders namely irritable bowel disorders and symptoms; pharmaceutical preparations for the treatment of gastrointestinal disorders; pharmaceutical preparations for the treatment of genetic disorders; pharmaceutical preparations for the treatment of genito-urinary and pelvic diseases, disorders and infections, namely infertility, sexually transmitted diseases, incontinence and sexual dysfunction; pharmaceutical preparations for the treatment of genitourinary diseases namely urological diseases and disorders; pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of glaucoma; pharmaceutical preparations for the treatment of gout; pharmaceutical preparations for the treatment of gynaecological diseases and disorders namely amenorrhoea, dysmenorrheal and infertility; pharmaceutical preparations for the treatment of headaches; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of hepatitis; pharmaceutical preparations for the treatment of hepatological diseases and disorders; pharmaceutical preparations for the treatment of hepatological related diseases namely hepatitis, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, liver fibroids, and cirrhosis; pharmaceutical preparations for the treatment of hereditary angioedema (HAE); pharmaceutical preparations for the treatment of hormonal disorders; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for the treatment of hormonal related diseases and disorders namely hypogonadism, testosterone, androgen and estrogen disorders; pharmaceutical preparations for the treatment of hypercholesteremia; pharmaceutical preparations for the treatment of hypercholesterolemia; pharmaceutical preparations for the treatment of hyperhydrosis; pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for the treatment of hypertension; pharmaceutical preparations for the treatment of idiopathic pulmonary fibrosis (IPF); pharmaceutical preparations for the treatment of immunologic diseases and disorders namely, autoimmune diseases and disorders; pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the treatment of incontinence, prostate diseases and disorders, bladder diseases and disorders; pharmaceutical preparations for the treatment of infectious diseases, namely respiratory infections, eye infections; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases, namely inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries; pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases; pharmaceutical preparations for the treatment of inflammatory muscle diseases and disorders; pharmaceutical preparations for the treatment of interstitial lung disease (ILD); pharmaceutical preparations for the treatment of kidney diseases; pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for the treatment of kidney disorders; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of liver diseases and disorders in animals; pharmaceutical preparations for the treatment of lysosomal storage diseases; pharmaceutical preparations for the treatment of malaria; pharmaceutical preparations for the treatment of mastitis; pharmaceutical preparations for the treatment of mental health disorders; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia; pharmaceutical preparations for the treatment of metabolic disorders, namely diabetes, bulimia nervosa, anorexia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of migraine; pharmaceutical preparations for the treatment of motion sickness; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for the treatment of multiple sclerosis, namely, topical creams containing cannabidiol; pharmaceutical preparations for the treatment of muscle dystonias; pharmaceutical preparations for the treatment of muscle spasms, tremors and pain; pharmaceutical preparations for the treatment of muscular dystrophy; pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders and injuries namely connective tissue diseases, bone diseases and osteoporosis; pharmaceutical preparations for the treatment of musculoskeletal disorders; pharmaceutical preparations for the treatment of myalgia and neuralgia; pharmaceutical preparations for the treatment of neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy; pharmaceutical preparations for the treatment of neurological diseases, namely, myasthenia gravis; pharmaceutical preparations for the treatment of neurological diseases, namely, myasthenia gravis, Alzheimer's, Huntington's Disease, cerebral palsy; pharmaceutical preparations for the treatment of neurological disorders, namely, brain injury, spinal cord injury, seizure disorders; pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, namely, cerebrovascular accident (stroke), Parkinson's disease, multiple sclerosis, myasthenia gravis, Huntington's disease; pharmaceutical preparations for the treatment of obesity; pharmaceutical preparations for the treatment of obesity in animals; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of ophthalmic conditions; pharmaceutical preparations for the treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment of opioid addiction; pharmaceutical preparations for the treatment of osteoporosis; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of Parkinson's disease; pharmaceutical preparations for the treatment of physical and psychological addictions, namely, gambling addiction, eating disorders and addictions, nicotine addiction, Internet addiction, drug addiction; pharmaceutical preparations for the treatment of physical and psychological addictions, namely, nicotine addiction; pharmaceutical preparations for the treatment of premenstrual dysphoric disorder, premenstrual syndrome, male hypogonadism and hormonal disorders namely polycystic ovary syndrome; pharmaceutical preparations for the treatment of presbyopia; pharmaceutical preparations for the treatment of primary hyperoxaluria; pharmaceutical preparations for the treatment of prostate disorders; pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia; pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders; pharmaceutical preparations for the treatment of pulmonary diseases and disorders; pharmaceutical preparations for the treatment of pulmonary hypertension; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases, disorders and infections; pharmaceutical preparations for the treatment of rosacea; pharmaceutical preparations for the treatment of sexual dysfunction; pharmaceutical preparations for the treatment of skin cancer; pharmaceutical preparations for the treatment of skin irritations, namely bee stings, sunburn, rashes, sores, corns, calluses, and acne; pharmaceutical preparations for the treatment of smoking cessation; pharmaceutical preparations for the treatment of smooth muscle disorders; pharmaceutical preparations for the treatment of sports injuries, namely, injured and torn skin, muscle, ligaments, and bone; pharmaceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the treatment of the central nervous system, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease; pharmaceutical preparations for the treatment of the diseases, disorders and infections of the central nervous system namely brain, movement, ocular motility and spinal cord diseases; pharmaceutical preparations for the treatment of the musculoskeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for the treatment of thrombosis; pharmaceutical preparations for the treatment of tuberculosis; pharmaceutical preparations for the treatment of urovaginal infections; pharmaceutical preparations for the treatment of varicose veins; pharmaceutical preparations for the treatment of vascular diseases; pharmaceutical preparations for the treatment of viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS); pharmaceutical preparations for the treatment of Wilson's disease; pharmaceutical preparations for the treatment of worms in pets; pharmaceutical preparations for the treatment of wrinkles; pharmaceutical preparations for the treatment of hypertension in animals; pharmaceutical preparations for the treatment of kidney diseases and disorders in animals; pharmaceutical preparations for treating allergic rhinitis; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for treating allergies; pharmaceutical preparations for treating and preventing skin and nail diseases; pharmaceutical preparations for treating asthma; pharmaceutical preparations for treating cardiovascular diseases; pharmaceutical preparations for treating chloasma; pharmaceutical preparations for treating dandruff; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating digestive system disorders; pharmaceutical preparations for treating dry skin caused by pregnancy; pharmaceutical preparations for treating gastrointestinal disorders; pharmaceutical preparations for treating halitosis; pharmaceutical preparations for treating heatstroke; pharmaceutical preparations for treating high cholesterol; pharmaceutical preparations for treating hypertension; pharmaceutical preparations for treating hypoglycaemia; pharmaceutical preparations for treating hypoglycemia; pharmaceutical preparations for treating malignant tumors; pharmaceutical preparations for treating malignant tumours; pharmaceutical preparations for treating opioid overdoses; pharmaceutical preparations for treating peripheral nervous system disorders; pharmaceutical preparations for treating physically caused lesions; pharmaceutical preparations for treating respiratory diseases; pharmaceutical preparations for treating sensory organ disorders; pharmaceutical preparations for treating sunburn; pharmaceutical preparations for treating the symptoms of radiation sickness; pharmaceutical preparations for treating the symptoms of menopause; pharmaceutical preparations for treatment of autoimmune diseases and disorders; pharmaceutical preparations for treatment of coronavirus; pharmaceutical preparations for treatment of coronavirus infection; pharmaceutical preparations for treatment of HIV and AIDS; pharmaceutical preparations for treatment of periodontitis, gingivitis, and pre-gingivitis; pharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders; pharmaceutical preparations for use in cell therapy; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases and treatment of acne; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in discouraging the smoking habit; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for use in gene therapy; pharmaceutical preparations for use in hematology, namely for the treatment of blood disorders; pharmaceutical preparations for use in immunomodulation therapies; pharmaceutical preparations for use in immunotherapies; pharmaceutical preparations for use in natural killer (NK) cell immunotherapy; pharmaceutical preparations for use in ocular disorders; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for use in T-cell immunotherapy; pharmaceutical preparations for use in the treatment of autoinflammatory diseases; pharmaceutical preparations for use in the treatment of immunological disorders; pharmaceutical preparations for use in the treatment of musculoskeletal diseases; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for use in urology; pharmaceutical preparations namely, anti-inflammatories; pharmaceutical preparations, namely non-opioid analgesics; pharmaceutical preparations, namely, preparations for the treatment of hyperacidity; pharmaceutical products and preparations against dry skin caused by pregnancy; pharmaceutical products and preparations for hydrating the skin during pregnancy; pharmaceutical products and preparations for the treatment and prevention of diseases caused by poxviruses, namely, smallpox and monkeypox; pharmaceutical products and preparations for the treatment of chloasma; pharmaceutical products and preparations for the treatment of dry skin associated with pregnancy; pharmaceutical products and preparations for the treatment of leg edema; pharmaceutical products for ophthalmological use; pharmaceutical products for the treatment of cancer; pharmaceutical products for the treatment of rare autoimmune diseases and disorders; pharmaceutical products for treating respiratory diseases; pharmaceutical solutions used in dialysis; pharmaceuticals for ophthalmological use; pharmaceuticals for the prevention and treatment of cancer; pharmaceuticals for the treatment of bone diseases; pharmaceuticals for the treatment of cancer; pharmaceuticals for the treatment of coronavirus diseases and COVID-19; pharmaceuticals for the treatment of erectile dysfunction; pharmaceuticals for treating dehydration; pharmaceuticals for treating respiratory diseases; pharmaceuticals for treating the symptoms of radiation sickness; pharmaceuticals, namely, compounded face cream containing estrogen; pharmaceuticals, namely, compounded sildenafil for women; pharmaceuticals, namely, compounded testosterone for hypoactive sexual desire disorder and low libido; plant protein isolates being dietary supplements; plant-based protein dietary supplements in powder form; plant-based supplements containing vegetable powders; plant-based supplements containing vitamins and minerals; powdered nutritional drink mix for the prevention and treatment of digestive diseases and disorders; powdered nutritional drink mix for the prevention and treatment of gastrointestinal diseases and disorders; powdered nutritional supplement drink mix for general health and well-being; powdered plant root for use as an ingredient in food supplements and herbal medicines to treat bronchial infections and the common cold; powdered whey proteins being nutritional supplements; pre-workout dietary supplements; pre-workout nutritional supplements; prebiotic supplements; probiotic bacteria as a food supplement; probiotic dietary supplements; probiotic dietary supplements in capsule form; probiotic supplements; probiotics for use as dietary supplements; protein dietary supplements; protein powder dietary supplements; protein powder nutritional supplements; protein powders for meal replacement for use as a dietary supplement; protein supplement shakes for weight gain purposes; protein supplements for humans; psilocybin botanical supplements for humans in form of oils and powders for recreational purposes; psilocybin botanical supplements in the form of oils and powders for the treatment of mental health disorders; soy isoflavone dietary supplements; soy protein dietary supplements; spirulina dietary supplements; synbiotic supplements; vegan protein for use as a nutritional supplement in ready-to-drink beverages; vitamin and mineral dietary supplements; vitamin and mineral food supplements; vitamin and mineral supplements; vitamin food supplements; vitamin supplement patches; vitamin supplements; vitamin supplements in tablet form for making effervescent beverages when added to water; whey protein concentrates being dietary supplements; whey protein hydrolysates being dietary supplements; whey protein isolates being dietary supplements; whey proteins being dietary supplements; whey proteins being food supplements; whey proteins being nutritional supplements; zinc dietary supplements; zinc supplement lozenges


Classification kind code

12

Mark Details


Serial Number

2399548

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 30
on 16th May 2025
Filed
Submitted for opposition 1
on 16th May 2025
Created
Submitted for opposition 31
on 16th May 2025
Formalized